Tonix Pharmaceuticals Presented Data on TONMYATM in Treating Patients with Fibromyalgia at the 2026 AAPM PainConnect Annual Meeting
· tonix pharmaceuticals holding corp.
AI Briefing
- TONMYA (cyclobenzaprine HCl sublingual tablets) is being investigated as a treatment for fibromyalgia, with data presented at the 2026 AAPM PainConnect Annual Meeting.
- TONMYA was commercially launched in November 2025.
- No additional information available.
Advertisement